semaglutide nad Medications like and Tirzepatide are not just for diabetes and weight loss! Major clinical trials like PIONEER 6 and SUSTAIN 6 have shown that Semaglutide also significantly reduces the risk of NAD+

The published data on tirzepatide suggest that second- and third-generation dual agonists and tritagonists, nicknamed double G or triple G, have the potential to be superior to semaglutide in obese patients (71, 145, 146)

After 72 weeks, the combo group had lost nearly 46 percent fat and almost 3 percent lean body mass, while the semaglutide group lost nearly 28 percent fat and over 7 percent lean body mass.

In clinical trials, the 12 mg dose produced 24.2% body weight loss at 48 weeks (Phase 2) and 28.7% at 68 weeks (Phase 3 TRIUMPH-4)

In non-hospitalized subjects, about 5075% may turn PASC-free one month after symptomatic onset 134

No insurance is billed, no referral is required, and no pre-authorization is needed

Its an ideal supplement to take just after your workouts to help maximize gains and potentially reduce soreness